Original Research Article
Mild Cognitive Impairment in General Practice: Age-Specific Prevalence and Correlate Results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)Luck T.a · Riedel-Heller S.G.a · Kaduszkiewicz H.b · Bickel H.c · Jessen F.d · Pentzek M.e · Wiese B.f · Koelsch H.d · van den Bussche H.b · Abholz H.-H.e · Moesch E.c · Gorfer S.g · Angermeyer M.C.a · Maier W.d · Weyerer S.g
aDepartment of Psychiatry, University of Leipzig, Leipzig, bInstitute for General Medicine, University Medical Centre, Hamburg, cDepartment of Psychiatry, Technical University of Munich, Munich, dDepartment of Psychiatry, University of Bonn, Bonn, eDepartment of General Practice, University Medical Centre, Düsseldorf, fInstitute for Biometrics, Hannover Medical School, Hannover, and gCentral Institute for Mental Health, Mannheim, Germany
Dipl.-Psych. Tobias Luck
Department of Psychiatry, University of Leipzig
DE–04317 Leipzig (Germany)
Tel. +49 341 972 4568, Fax +49 341 972 4539, E-Mail email@example.com
Do you have an account?
Background: Although mild cognitive impairment (MCI) represents a high-risk factor for developing dementia, little is known about the prevalence of MCI among patients of general practitioners (GPs). Aims: Estimation of age-specific prevalence for original and modified concepts of MCI and their association with sociodemographic, medical and genetic (apoE Ε4 genotype) factors among patients of GPs. Methods: A GP practice sample of 3,327 individuals aged 75+ was assessed by structured clinical interviews. Results: Prevalence was 15.4% (95% CI = 14.1–16.6) for original and 25.2% (95% CI = 23.7–26.7) for modified MCI. Rates increased significantly with older age. Positive associations were found for apoE Ε4 allele, vascular diseases and depressive symptoms. Conclusion: MCI is frequent in elderly patients of GPs. GPs have a key position in secondary prevention and care of incipient cognitive deterioration up to the diagnosis of dementia.
© 2007 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.